1、Diversity and clinical trials Diversity and clinical trials in the UKin the UKFebruary 2024Clinical trials have a diversity blind spotClinical trials are critical to the development of medicines and devices to improve the health and wellbeing of people around the world.However,trials have historical

2、ly failed to engage a diverse group of participants from different ethnic and racial backgrounds.Creating more supportive environments for a diverse range of individuals to participate in clinical trials is a critical step in achieving health equity.Getting a clear view of how people currently think

3、 about clinical trials can help us identify what steps need to be taken to make this a reality.We conducted research to understand differences between white and ethnic minority adults in the UK when it comes toAwareness,knowledge and perception of clinical trials Clinical trial participation Key bar

4、riers and motivators to participation 123TARGETGeneral Public Age 16+based in the UKSAMPLE SIZEN=8,206 HEALTH HISTORY59.6%had any medical condition*GENDERMale 48%Female:52%RACE/ETHNICITY*White:88%/Asian:8%Black/African/Caribbean:2%Other Ethnicity:2%*Primarily,Mental health 19%,Arthritis 13%,Asthma 1

5、2%,Hypertension 12%*White;including White minorities*n=39 did not use internet,primarily White(n=32),in England(n=33),55+(n=36)We conducted a survey among a nationally representative sample of over 8,000 adults in the UK,12%of whom were ethnic minoritiesINTERNET ACCESS99%had access to internet*METHO

6、DOLOGY8-min nationally representative survey run by Ipsos KnowledgePanel between 14-20 September 202341%of Ethnic Minority respondents*Base:All respondents(n=8206)QA6:How willing or not would you be to participate in a clinical trial in the future?You can answer this question whether or not you have